MedTrace Logo

Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems

NCT05423340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2025-01-29

No results posted yet for this study

Summary

This is a randomized, parallel-group open-label trial to evaluate respiratory symptoms in ENDS users switching from banned flavors to a non-banned flavor (tobacco) or 'tobacco free' nicotine pouches.

Conditions

  • Electronic Cigarette Use

Interventions

OTHER

E-cigarette Flavor

Participants use an electronic nicotine delivery system with an assigned tobacco-flavored e-liquid

OTHER

Tobacco Free Nicotine Pouch

participants will use tobacco free oral nicotine pouches

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Cancer Institute (NCI)

    collaborator NIH

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Maciej Goniewicz, PhD · Roswell Park

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-12
Primary Completion
2024-10-03
Completion
2024-10-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05423340 on ClinicalTrials.gov